LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 211,600 shares, a drop of 34.3% from the March 15th total of 322,100 shares. Currently, 1.5% of the company’s stock are sold short. Based on an average daily volume of […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 9,200 shares, an increase of 15.0% from the December 31st total of 8,000 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading […]
Health care stocks were declining Thursday afternoon, with the NYSE Health Care Index falling 1% and the Health Care Select Sector SPDR Fund down 0.9%.
The iShares Biotechnology ETF rose.
By Rob Curran Lava Therapeutics shares surged after the biotech company said one of its product candidates would be tested on prostate-cancer patients in.
Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.